Articles Tập 67 Số CĐ9-Hội Y học Giới tính 29/07/2026

PRELIMINARY OUTCOMES OF REZŪM WATER VAPOR THERAPY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

Nguyen Dinh Lien1,2,3,4, Nguyen The Thinh1,2,3,4, Nguyen Minh Tuan5,6, Vo Van Quy7,8
1 Vietnam National University, Hanoi
2 E Hospital
3 Trường Đại học Y Dược, Đại học Quốc gia Hà Nội
4 Bệnh viện E
5 Bach Mai Hospital
6 Bệnh viện Bạch Mai
7 Hanoi French Hospital
8 Bệnh viện Việt Pháp Hà Nội
DOI: 10.52163/yhc.v67iCD9.5820
52 Views
0 Downloads
Keywords
Rezūm, benign prostatic hyperplasia, LUTS, TURP.
Abstract

Objective: To evaluate the efficacy and safety of Rezūm therapy through the first three clinical cases, with a discussion on the role of Rezūm compared to transurethral resection of the prostate in the current management of benign prostatic hyperplasia.

Methods: A descriptive study of three benign prostatic hyperplasia cases treated with Rezūm therapy, including patient selection criteria, procedural technique, and pre- and post-treatment assessments: international prostate symptom score, quality of life score, post-void residual urine volume, prostate size reduction, complications, and sexual function.

Results: After 3 months of follow-up, all three patients showed significant improvements: international prostate symptom score decreased by 77.8-80%, quality of life improved by 80%, and post-void residual was markedly reduced. Prostate volume decreased on both ultrasound and magnetic resonance imaging after 3 months. The duration of indwelling urinary catheterization ranged from 10 to 14 days. No procedure-related complications were reported. Sexual function was preserved in two patients, the remaining case could not be evaluated due to pre-existing erectile dysfunction.

Conclu

Rezūm, benign prostatic hyperplasia, LUTS, TURP.

 

sion: Rezūm therapy is a safe, effective, and minimally invasive treatment option for patients with lower urinary tract symptoms/benign prostatic hyperplasia, with the notable advantages of preserving sexual function and enabling rapid recovery. It may serve as a suitable alternative to transurethral resection of the prostate in appropriately selected cases.

References
[1]
Lerner L.B, McVary K.T et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I-initial work-up and medical management. The Journal of Urology, 2021, 206 (4): 806-817. Google Scholar
[2]
Westwood J, Geraghty R et al. Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia. Therapeutic Advances in Urology, 2018, 10 (11): 327-333. Google Scholar
[3]
Roehrborn C.G. Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. Reviews in Urology, 2008, 10 (1): 14-25. Google Scholar
[4]
Rassweiler J, Teber D et al. Complications of transurethral resection of the prostate (TURP) - incidence, management, and prevention. European Urology, 2006, 50 (5): 969-980. Google Scholar
[5]
Darson M.F, Alexander E.E et al. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Research and Reports in Urology, 2017, 9: 159-168. doi: 10.2147/RRU.S143679 Google Scholar
[6]
Dixon C, Cedano E.R et al. Efficacy and safety of Rezūm system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology, 2015, 86 (5): 1042-1047. Google Scholar
[7]
McVary K.T, Roehrborn C.G. Three-year outcomes of the prospective, randomized controlled Rezūm system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology, 2018, 111: 1-9. doi: 10.1016/j.urology.2017.10.023. Google Scholar
[8]
Alegorides C, Fourmarier M et al. Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: results at one year. Progrès en Urologie, 2020, 30 (12): 624-631. Google Scholar
[9]
Garden E.B, Shukla D et al. Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes. World Journal of Urology, 2021, 39 (8): 3041-3048. Google Scholar
[10]
Rowaiee R, Akhras A et al. Rezum therapy for benign prostatic hyperplasia: Dubai’s initial experience. Cureus, 2021, 13 (9) : e18083. doi: 10.7759/cureus.18083. Google Scholar